Loading chart…
CLOSED
Anlon Healthcare Limited manufactures and sells active pharmaceutical ingredients in India and internationally. The company also offers bulk drugs; advanced pharmaceutical intermediates; nutraceutical API products; and drug intermediates. It also manufactures loxoprofen sodium dihydrate, ketoprofen, and dexketoprofen trometamol products for pain management and anti-inflammatory therapies.
Anlon Healthcare Limited (AHCL) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The AHCL share price is ₹26.94 (-0.22% today), with a market capitalisation of ₹14B and a price-to-earnings (P/E) ratio of 50.8. MarketRipple tracks the AHCL investment thesis, the ripple-chain impact of market events on Anlon Healthcare Limited, and the Healthcare sector outlook.
Open
₹28.00
High
₹28.20
Low
₹26.76
Prev. Close
₹27.00
52W High
₹37.24
52W Low
₹10.37
Day range
₹26.76–₹28.20
52-week range
₹10.37–₹37.24
Volume
2.0M
P/E
50.8
ROE
16.4%
D/E
0.19
Margin
12.8%
Anlon Healthcare Limited (NSE: AHCL) is currently trading at ₹26.94 (-0.22%).
Anlon Healthcare Limited's market capitalization is ₹14B.
Anlon Healthcare Limited's price-to-earnings (P/E) ratio is 50.8.
Anlon Healthcare Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).